- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Iconovo (ICO)
The Iconovo share price today is 1.22, view ST ICO stock exchange data. Track the latest Iconovo share price with real-time updates on ICO stock performance including market cap, day range, 52-week range and dividend yield. Access ICO charts, earnings dates and analyst estimates to support your investment decisions.
Stockholm
Currency in SEK
1.22
+0.03(+2.52%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.16
1.22
52 wk Range
0.91
2.79
ICO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.161.22
52 wk Range
0.912.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ICO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Iconovo Earnings Call Summary for Q4/2025
- Iconovo Q4 2025 revenue of 500,000 exceeded forecast by 25%, but posted negative EPS of -0.24, triggering 2.68% pre-market stock decline.
- Company reduced personnel costs 40% year-over-year as part of strategic shift from platform development to business-focused pharmaceutical firm.
- CEO Anders Månsson emphasized partnerships as growth driver, with ICOres European partnership and ICOpre financing expected within fiscal year.
- Iconovo raised SEK 50 million to fund operations through next fiscal year; stock trading near 52-week low amid profitability concerns.
- Management targeting advanced-stage European partnership for ICOres project with Amneal while focusing on cost optimization and strategic initiatives.
Last Updated: 02-03-2026, 05:02 pm
Read Full TranscriptEarnings
Latest Release
27-04-2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare ICO to Peers and Sector
Metrics to compare | ICO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipICOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.9x | 29.2x | −0.5x | |
PEG Ratio | −0.04 | −0.20 | 0.00 | |
Price/Book | 0.7x | 5.9x | 2.6x | |
Price / LTM Sales | 8.5x | 4.9x | 3.2x | |
Upside (Analyst Target) | −34.4% | 42.3% | 48.1% | |
Fair Value Upside | Unlock | 9.7% | 6.6% | Unlock |
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreement with Lonza to develop spray-dried formulations of an intranasal biologic drug; and agreement with Kiox Pharma to develop an inhalable treatment for interstitial lung disease. Iconovo AB (publ) was founded in 2013 and is headquartered in Lund, Sweden.
FAQ
What Is the Iconovo (ICO) Share Price Today?
The Iconovo share price today is 1.22.
What is the current Iconovo (ICO) share price and day range?
As of 03-05-2026, the Iconovo share price is 1.22, with a previous close of 1.19. The share price has ranged from 1.16 to 1.22 today, while the 52-week range spans from 0.91 to 2.79.
What Is the Iconovo Market Cap?
As of today, Iconovo market cap is 116.85M.
What Is the Iconovo (ICO) Share Price Target?
The average 12-month share price target for Iconovo is 0.80, with a high estimate of 0.8 and a low estimate of 0.8. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and -34.43% Downside potential.
What Is Iconovo's Earnings Per Share (TTM)?
The Iconovo EPS (TTM) is -0.77.
When Is the Next Iconovo Earnings Date?
Iconovo will release its next earnings report on 27-04-2026.
From a Technical Analysis Perspective, Is ICO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Iconovo Trade On?
Iconovo is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Iconovo?
The stock symbol for Iconovo is "ICO."
How Many Times Has Iconovo Stock Split?
Iconovo has split 0 times.
How Many Employees Does Iconovo Have?
Iconovo has 12 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.